About
Edward van Wezel is a Dutch life sciences venture capitalist and the co-founder and Managing Partner of BioGeneration Ventures, an early-stage European biopharma VC firm. His background includes roles at Chiron, Johnson & Johnson, and several Dutch life sciences companies before moving into venture investing and company creation. He also holds multiple supervisory and board roles across BGV portfolio companies and the Dutch life sciences infrastructure foundation Mibiton.
Areas of interest
biotechbiopharmadrug discoveryoncologyrare diseasesrare metabolic disordersantibody-drug conjugatesGPCR therapeuticsantibody therapeuticscompany creationearly-stage venture capital